Annick Schwebig
Director/Board Member bei INVENTIVA
Vermögen: 16 242 $ am 31.03.2024
Profil
Annick Schwebig was the founder and held the position of Chairman & Chief Executive Officer at Actelion Pharmaceuticals, Inc. (France) from 2000 to 2016.
Dr. Schwebig's current job(s) include Chairman-Management Board at ESSEC Business School, Vice Chairman-Supervisory Board at Inserm-Transfert SA, Director at B Cell Design SAS, Independent Director at Inventiva SA since 2017, and Secretary at Alliance for Research & Innovation in Health Industries.
Dr. Schwebig's former job(s) include Vice Chairman-Supervisory Board at INSERM Transfert SA, Director at Diatos SA, Independent Director at Cellectis SA from 2011 to 2023, and GM, VP-Medical Affairs & Research Development at Bristol-Myers Squibb SARL from 1983 to 2000.
Dr. Schwebig's education history includes undergraduate and doctorate degrees from Université Paris 1 Panthéon-Sorbonne.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
INVENTIVA SA
0,01% | 01.03.2024 | 3 076 ( 0,01% ) | 11 029 $ | 31.03.2024 |
CELLECTIS SA
0,00% | 14.02.2023 | 1 940 ( 0,00% ) | 5 213 $ | 31.03.2024 |
Aktive Positionen von Annick Schwebig
| Unternehmen | Position | Beginn |
|---|---|---|
| INVENTIVA | Director/Board Member | 01.02.2017 |
| Alliance for Research & Innovation in Health Industries | Corporate Secretary | - |
B Cell Design SAS
 B Cell Design SAS Miscellaneous Commercial ServicesCommercial Services B Cell Design SAS provides pharmaceutical services. It offers research and development services in producing antibodies. The firm serves as a platform for other diagnostic and pharmaceutical companies addressed to academic laboratories and industrial research. The company was founded in December 7, 2007 and is headquartered in Limoges, France. | Director/Board Member | - |
Inserm-Transfert SA
 Inserm-Transfert SA Miscellaneous Commercial ServicesCommercial Services Inserm-Transfert SA engages in the managements of economic and societal value creation and the transfer of knowledge. It operates in the human health innovation sector. The company was founded in 2000 and is headquartered in Paris, France. | Director/Board Member | - |
| ESSEC Business School | Chief Executive Officer | - |
Ehemalige bekannte Positionen von Annick Schwebig
| Unternehmen | Position | Ende |
|---|---|---|
| CELLECTIS S.A. | Director/Board Member | 27.06.2023 |
INSERM Transfert SA
 INSERM Transfert SA Investment ManagersFinance INSERM Transfert SA is a Venture Capital firm, a subsidiary of Institut National de la Sant? et de la Recherche M?dicale founded in 2000. INSERM Transfert SA is headquartered in Paris, France. | Director/Board Member | 10.09.2019 |
Actelion Pharmaceuticals, Inc. (France)
 Actelion Pharmaceuticals, Inc. (France) Industrial SpecialtiesProcess Industries Actelion Pharmaceuticals, Inc. (France) is a private company based in Le Pin, France. and has subsidiaries in France. Actelion Pharmaceuticals, Inc. manufactures insulation materials. The French company was founded by Annick Schwebig. | Chief Executive Officer | 01.01.2016 |
Diatos SA
 Diatos SA Pharmaceuticals: MajorHealth Technology Diatos SA develops innovative therapies for the treatment of cancer. The firm leverages its peptide-based, intracellular drug delivery & tumor targeting technologies to improve the properties of existing therapeutics. Its products include DaunoXome, DTS-301 and DTS-108. The company was founded in 1999 and headquartered in Paris, France. | Director/Board Member | 15.09.2009 |
| ░░░░░░░░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Annick Schwebig
| Université Paris 1 Panthéon-Sorbonne | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| CELLECTIS S.A. | Health Technology |
| INVENTIVA | Health Technology |
| Private Unternehmen | 7 |
|---|---|
Diatos SA
Diatos SA Pharmaceuticals: MajorHealth Technology Diatos SA develops innovative therapies for the treatment of cancer. The firm leverages its peptide-based, intracellular drug delivery & tumor targeting technologies to improve the properties of existing therapeutics. Its products include DaunoXome, DTS-301 and DTS-108. The company was founded in 1999 and headquartered in Paris, France. | Health Technology |
Actelion Pharmaceuticals, Inc. (France)
Actelion Pharmaceuticals, Inc. (France) Industrial SpecialtiesProcess Industries Actelion Pharmaceuticals, Inc. (France) is a private company based in Le Pin, France. and has subsidiaries in France. Actelion Pharmaceuticals, Inc. manufactures insulation materials. The French company was founded by Annick Schwebig. | Process Industries |
INSERM Transfert SA
INSERM Transfert SA Investment ManagersFinance INSERM Transfert SA is a Venture Capital firm, a subsidiary of Institut National de la Sant? et de la Recherche M?dicale founded in 2000. INSERM Transfert SA is headquartered in Paris, France. | Finance |
Bristol-Myers Squibb SARL
 Bristol-Myers Squibb SARL Medical DistributorsDistribution Services Bristol-Myers Squibb SARL engages in the research, development, manufacture, and distribution of pharmaceutical products. Its therapeutic areas include immunoscience, immune-oncology, and cardiology. The company is headquartered in Rueil-Malmaison, France. | Distribution Services |
| Alliance for Research & Innovation in Health Industries | |
Inserm-Transfert SA
Inserm-Transfert SA Miscellaneous Commercial ServicesCommercial Services Inserm-Transfert SA engages in the managements of economic and societal value creation and the transfer of knowledge. It operates in the human health innovation sector. The company was founded in 2000 and is headquartered in Paris, France. | Commercial Services |
B Cell Design SAS
B Cell Design SAS Miscellaneous Commercial ServicesCommercial Services B Cell Design SAS provides pharmaceutical services. It offers research and development services in producing antibodies. The firm serves as a platform for other diagnostic and pharmaceutical companies addressed to academic laboratories and industrial research. The company was founded in December 7, 2007 and is headquartered in Limoges, France. | Commercial Services |
